Skip to content

Rx Americas: Antiretroviral Therapy in Latin America: North of the Southern Cone, a Good Plan Is Hard to Find

TAGline • 2003
Antiretroviral Therapy in Latin America: North of the Southern Cone, a Good Plan Is Hard to Find By Richard Stern Seguro Social or Bust When Agua Buena’s Richard Stern writes, below, about a recent trip to the AIDS hospitals and advocacy groups of Lima, Perú, he could just as easily been describing the situation in…

Tipping Point: MSF, Oxfam Redefine the Possible, and Y2K Activist Trek to Durban Marks a Watershed

TAGline • 2003
MSF, Oxfam Redefine the Possible, and Y2K Activist Trek to Durban Marks a Watershed By David Barr Small Piece of History The buzz before Durban was all about security. The crime would be terrible. No one would be able to step outside their hotel rooms without being macheted to pieces. Also, there were no hotel…

TAG Postition Paper on Fosamprenavir Approval

Publication • 2003
And speaking of boosting… By Rob Camp and Heidi Nass December 2003 Executive Summary FDA granted accelerated approval to Agenerase® brand amprenavir (NDA 21-007 and NDA 21-039) in April 1999. 908 allows us an opportunity to get an easier-to-use drug from the same molecule. In fact, over the last four years, clinical management questions have…

Fuzeon Brand Enfuvirtide (T-20): Breaking Barriers or Breaking the Bank?

Publication • 2003
By Matt Sharp and Rob Camp for the Treatment Action Group (TAG) and Other Endorsing Community Organizations and Individuals (List Below) March 7, 2003 Introduction Research and advocacy have brought forth 16 approved antiviral medications targeting two different stages in the HIV lifecycle. These drugs, when used in potent combinations, have significantly reduced morbidity and…

Revenge of the CTLs: Harvard Vaccine Team Exposes Potential Dark Side of Reliance on Cellular Immune Protection

TAGline • 2002
Harvard Vaccine Team Exposes Potential Dark Side of Reliance on Cellular Immune Protection The Fate of Monkey #798 By Richard Jeffreys January 2002 proved to be a month of mixed blessings for the AIDS vaccine field. A slew of new papers in the prestigious journal Nature publicly highlighted both the promise and potential pitfalls of…

Activism = Hope: TAG Elder/Alumnus Remembers Struggles Past and Present With Humility, Nostalgia, Foreboding

TAGline • 2002
TAG Elder/Alumnus Remembers Struggles Past and Present With Humility, Nostalgia, Foreboding “Rabid Vaccine Pollyannas” By Gregg Gonsalves “Hope” is the thing with feathers That perches in the soul And sings the tune without the words And never stops at all, And sweetest in the gale is heard; And sore must be the storm That could…

Enemies at the Gate: Storming Montréal’s Palais de Congrès, and Makeshift Battle Stations in Fortress San Francisco

TAGline • 2002
Storming Montréal’s Palais de Congrès, and Makeshift Battle Stations in Fortress San Francisco By David Barr Bodyguarded Investigators It could be said that NIH-activist relations reached their untenable nadir in 1990. Nearly 30,000 Americans had died of AIDS the previous year, and the National Academy of Sciences announced that the disease would cause more than…

TAG at Ten: The Year 1998

TAGline • 2002
January: TAG community meeting at which John Moore gives update on vaccine research. TAG board member Marvin Shulman says farewell to New York life and heads for a full-time residency in South Miami Beach. FDA approves dental dams. Monica Lewinsky scandal erupts. Michael Marco finishes The OI Report, version 2.0. March: Glaxo announces 67 percent…

Co-Conspirators: HIV Spread Threatens Decade’s Tuberculosis Treatment/Prevention Success

TAGline • 2002
HIV Spread Threatens Decade’s Tuberculosis Treatment/Prevention Success By Daniel Raymond New Challenges, Questions TB researchers and policy-makers from around the world gathered on 3-5 June 2002 in Washington, D.C., at the 4th World TB Congress (the 3rd was held ten years ago) to mark progress and map out the next stages of the global campaign…

Community Rx: Scrapping Volunteer Model Meant Curtains for Activist Conscripts and Paved Way for TAG Ascendency

TAGline • 2002
Scrapping Volunteer Model Meant Curtains for Activist Conscripts and Paved Way for TAG Ascendency By David Barr “Urgent Need to Teach, Train” Survey the leadership of major AIDS advocacy organizations, scan the mastheads of treatment publications, and chances are you’ll come across name after name of T+D and TAG alumni/ae. Peppered throughout the ranks of…
Back To Top